TMO - Thermo Fisher Scientific Inc.
(NaN%)
SNP 500
Sell
Moderate Growth but Declining●Stock Price High
58%
based on last 5 year data.
Income Statement is STRONG
Revenue Growth is -4.58%
Operating Income Growth is -18.28%
Net Income Growth is -13.74%
Earnings Per Share (EPS) Growth is -12.37%
Net Margin is 13.99%
Balance Sheet is MODERATE
Current Asset to Current Liability Ratio is 1.75
Debt Ratio is 0.19
Current Debt to Net Income Ratio is 0.6
Total Debt to Total Assets Ratio is 0.35
Cash Flow is MODERATE
Cash from Operations Growth is -8.17%
Capital Expenditure is Low
Net Increase in Cash is Negative
Long Term Score Trend is NEGATIVE
Investment Risk is Moderate
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Thermo Fisher Scientific Inc. (TMO) - https://www.thermofisher.com/
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally.Exchange - NEW YORK STOCK EXCHANGE INC.
Industry - Other Measuring and Controlling Device Manufacturing
Sector - Manufacturing
CEO - Marc Casper
Employees - 130,000
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2024 and future.
Know the Stock © 2024 and future.